OnDemand: March 2024 Grand Rounds - Bariatric Surgery: It’s Not What You Think - Molecular Underpinnings of Surgical Interventions-Bariatric Surgery: It’s Not What You Think - Molecular Underpinnings of Surgical Interventions

Bariatric Surgery: It’s Not What You Think - Molecular Underpinnings of Surgical Interventions

Video Transcription

Video Summary

Dr. Randy Seeley explained that the gut is not just a passive digestive tube but a highly adaptable organ with barrier, absorptive, immune, endocrine, and regenerative functions. He argued that obesity and metabolic disease are better understood through the gut-brain axis and “enteroplasticity,” the gut’s ability to adapt to changing conditions.  <br /><br />A major focus was bariatric surgery, especially vertical sleeve gastrectomy and Roux-en-Y gastric bypass. Although these procedures look mechanically different, they produce remarkably similar clinical benefits, including weight loss and improved glucose control. Seeley argued these effects are not simply due to restriction or malabsorption. In animal studies, surgery changes food preferences, lowers preference for fat, alters gastric emptying, increases GLP-1, changes bile acid signaling, and affects iron handling.  <br /><br />He highlighted two key mechanisms: HIF-2 signaling and the antimicrobial peptide Reg3γ. Changes in iron homeostasis appear to activate HIF-2 pathways, which can mimic some surgery benefits. Reg3γ improves gut barrier function and is required for many metabolic benefits of surgery, including better glucose tolerance, insulin secretion, and reduced liver fat.  <br /><br />Overall, Seeley proposed that bariatric surgery works by reprogramming gut biology, which then improves metabolism, rather than by simple mechanical restriction alone.

Keywords

gut-brain axis

bariatric surgery

vertical sleeve gastrectomy

Roux-en-Y gastric bypass

enteroplasticity

GLP-1

HIF-2 signaling

Reg3γ

metabolic disease